Bioequivalence clinical trial of two formulations of ezetimibe/atorvastatin

Status

Completed

Phases

Phase 1

Study type

Interventional

Source

EU CTIS

Registry ID

CTIS2023-506559-10-00

Acronym

N-EZEATO-23-280

Enrollment

Registered

2023-09-06

Start date

2023-09-07

Completion date

2023-11-07

Last updated

2023-09-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy volunteers

None listed

Sex/Gender

All

Age

18 Years to 64 Years

Spain

None listed

Source: EU CTIS · Data processed: Feb 4, 2026